Art

J-GLOBAL ID：202102221088422527   Reference number：21A0779384

Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1α

Piceatanolのアルブミンナノカプセル化は核p65とHIF-1αのダウンレギュレーションを介してColon癌における抗癌性を増強する【JST・京大機械翻訳】

Author (34)： Aljabali Alaa A. A. (Department of Pharmaceutical Sciences, Yarmouk University-Faculty of Pharmacy, Irbid 566, Jordan) ,  Bakshi Hamid A. (School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK) ,  Hakkim Faruck L. (Department of Mathematics and Sciences, College of Arts and Applied Sciences Dhofar University Salalah, Salalah 211, Oman) ,  Haggag Yusuf A. (Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Tanta, Tanta 31111, Egypt) ,  Al-Batanyeh Khalid M. (Department of Biological Sciences, Yarmouk University-Faculty of Science, Irbid 566, Jordan) ,  Zoubi Mazhar S. Al (Department of Basic Medical Sciences, Yarmouk University-Faculty of Medicine, Irbid 566, Jordan) ,  Al-Trad Bahaa (Department of Biological Sciences, Yarmouk University-Faculty of Science, Irbid 566, Jordan) ,  Nasef Mohamed M. (Department of Pharmacy and Biomedical Sciences, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK) ,  Satija Saurabh (School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India) ,  Mehta Meenu (School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India) ,  Pabreja Kavita (School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India) ,  Mishra Vijay (School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India) ,  Khan Mohammed (School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK) ,  Abobaker Salem (Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow, Klinikum Charite-Universitatmedizin Berlin, augustenburger Platz 1, 13353 Berlin, Germany) ,  Azzouz Ibrahim M. (Department of Dermatology, Venerology, and allergology, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Chariteplatz1, 10117 Berlin, Germany) ,  Dureja Harish (Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak 124001, India) ,  Pabari Ritesh M. (School of Pharmacy, Royal College of Surgeons in Ireland, Dublin-09 D02 YN77, Ireland) ,  Dardouri Ashref Ali K. (Department of Forensic Science, School of Applied Science, Huddersfield University, Queensgate, Huddersfield HD1 3DH, UK) ,  Kesharwani Prashant (Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India) ,  Gupta Gaurav (School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur 302017, India) ,  Shukla Shakti Dhar (Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 230, Australia) ,  Prasher Parteek (Department of Chemistry, University of Petroleum & Energy Studies, Dehradun 248007, India) ,  Charbe Nitin B. (Departamento de Quimica Organica, Facultad de Quimica y de Farmacia, Pontificia Universidad Catolica de Chile, Av. Vicuna McKenna 4860, 7820436, Macul, Santiago 4860, Chile) ,  Negi Poonam (School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, India 173229, India) ,  Kapoor Deepak N. (School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, India 173229, India) ,  Chellappan Dinesh Kumar (Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia) ,  Silva Mateus Webba da (School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK) ,  Thompson Paul (School of Biomedical Sciences, University of Ulster, Coleraine BT52 1SA, UK) ,  Dua Kamal (Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 230, Australia) ,  Dua Kamal (School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, India 173229, India) ,  Dua Kamal (Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, NSW 2007, Australia) ,  Dua Kamal (Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia) ,  McCarron Paul (School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK) ,  Tambuwala Murtaza M. (School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK)
Material： Cancers (Web)
Volume： 12  Issue： 1  Page： 113  Publication year： 2020 
JST Material Number： U7153A  ISSN： 2072-6694  Document type： Article
Article type： 原著論文  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Piceatannol (PIC) is known to ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0779384&from=J-GLOBAL&jstjournalNo=U7153A") }}

Thesaurus term： *albumin ,  *antitumor action ,  antitumor drug ,  tumor cell ,  human(primates) ,  colitis(large intestine) ,  *down-regulation ,  colonic neoplasm ,  NF-kappaB ,  nano particle
Semi thesaurus term： ウシ血清アルブミン ,  *p65 ,  コロニー形成 ,  結腸直腸癌 ,  マウスモデル , 【Automatic Indexing@JST】

Author keywords (5)： piceatannol ,  colon cancer ,  albumin nanoparticles ,  nuclear P65 ,  HIF-1α

JST classification (2)： Basic research of antitumor(=antineoplastic)drugs  (GW16010A) ,  Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N)

Reference (73)：

• Merrill, R.M.; Anderson, A.E. Risk-adjusted colon and rectal cancer incidence rates in the United States. Dis. Colon Rectum 2011, 54, 1301-1306.
• Bray, F.; Ren, J.-S.; Masuyer, E.; Ferlay, J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int. J. Cancer 2013, 132, 1133-1145.
• Ferlay, J.; Seorjomataram, I.; Dikshit, R.; Eser, E.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 2015, 136, E359-E386.
• Data Were Provided by the Office for National Statistics on Request, July 2017. Available online: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases (accessed on 26 April 2019).
• Santandreu, F.M.; Valle, A.; Oliver, J.; Roca, P. Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells. Cell. Physiol. Biochem. 2011, 28, 219-228.

Terms in the title (9)： アルブミン ,  ナノカプセル化 ,  核 ,  p65 ,  HIF-1α ,  ダウンレギュレーション ,  癌 ,  抗癌性 ,  増強